Biotek-snakken — Februar 2026
-
PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s
year-end report for the period January – December 2025 https://cdn.bequoted.com/media/1/2e08febe-36c8-4704-bcd7-199fa6b0e831/Pila_Pharma_Pressrelease_2026-02-10.pdf -
@Darvin - Ja; Curasight ligger ikke på den lade sig - Dagens udmelding om deltagelse i TD Cowen konferencen 3. marts med pæsentation og 1-1 møder lyder spændende. De fisker efter partneraftale. https://news.cision.com/curasight/r/curasight-to-present-at-td-cowen-s-46th-annual-health-care-conference-in-boston,c4308454
-
Initiator Pharma A/S granted European patent for pudafensine in Female Sexual Dysfunction, including vulvodynia
https://www.nordnet.dk/markedet/nyheder/2eb95538-e9a8-4e13-85c7-ae0ecc7583aa -
Saniona afholder investor konference 26 Feb. https://saniona.com/newsroom/single-press-release/?slug=invitation-to-saniona-q4-and-year-end-investor-call-on-26-february-2026
-
Saniona årsrapport 2025. https://saniona.com/newsroom/press-releases/
-
Gubra tidoblede omsætningen efter milliardaftale med Abbvie https://proinvestor.com/investornyt/1415516/gubra-tidoblede-omsaetningen-efter-milliardaftale-med-abbvie
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind

